NEWLY DIAGNOSED MULTIPLE MYELOMA
Clinical trials for NEWLY DIAGNOSED MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new NEWLY DIAGNOSED MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for NEWLY DIAGNOSED MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for myeloma patients: ELDORADO trial tests powerful drug combo without transplant
Disease control Not yet recruitingThis study tests whether a new drug combination (elranatamab plus standard medications) works better than the current standard (daratumumab plus standard medications) for people newly diagnosed with multiple myeloma who are not eligible for or choose not to have a stem cell trans…
Matched conditions: NEWLY DIAGNOSED MULTIPLE MYELOMA
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 26, 2026 10:55 UTC
-
New cocktail of drugs shows promise for myeloma patients who Can't have transplant
Disease control Not yet recruitingThis study is for people newly diagnosed with multiple myeloma who cannot have or choose not to have a stem cell transplant. Researchers are testing a combination of four drugs (isatuximab, iberdomide, bortezomib, and dexamethasone) to find the safest dose and see how well it con…
Matched conditions: NEWLY DIAGNOSED MULTIPLE MYELOMA
Phase: PHASE1, PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 26, 2026 10:53 UTC